222 related articles for article (PubMed ID: 30300689)
1. The Needs and Benefits of Continuous Model Updates on the Accuracy of RT-Induced Toxicity Prediction Models Within a Learning Health System.
Nakatsugawa M; Cheng Z; Kiess A; Choflet A; Bowers M; Utsunomiya K; Sugiyama S; Wong J; Quon H; McNutt T
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):460-467. PubMed ID: 30300689
[TBL] [Abstract][Full Text] [Related]
2. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
[TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
[TBL] [Abstract][Full Text] [Related]
4. Parotid gland fat related Magnetic Resonance image biomarkers improve prediction of late radiation-induced xerostomia.
van Dijk LV; Thor M; Steenbakkers RJHM; Apte A; Zhai TT; Borra R; Noordzij W; Estilo C; Lee N; Langendijk JA; Deasy JO; Sijtsema NM
Radiother Oncol; 2018 Sep; 128(3):459-466. PubMed ID: 29958772
[TBL] [Abstract][Full Text] [Related]
5. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
Beetz I; Schilstra C; van der Schaaf A; van den Heuvel ER; Doornaert P; van Luijk P; Vissink A; van der Laan BF; Leemans CR; Bijl HP; Christianen ME; Steenbakkers RJ; Langendijk JA
Radiother Oncol; 2012 Oct; 105(1):101-6. PubMed ID: 22516776
[TBL] [Abstract][Full Text] [Related]
6. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors.
Beetz I; Schilstra C; Burlage FR; Koken PW; Doornaert P; Bijl HP; Chouvalova O; Leemans CR; de Bock GH; Christianen ME; van der Laan BF; Vissink A; Steenbakkers RJ; Langendijk JA
Radiother Oncol; 2012 Oct; 105(1):86-93. PubMed ID: 21632133
[TBL] [Abstract][Full Text] [Related]
7. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
Strigari L; Benassi M; Arcangeli G; Bruzzaniti V; Giovinazzo G; Marucci L
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):269-76. PubMed ID: 20100642
[TBL] [Abstract][Full Text] [Related]
8. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
Marzi S; Iaccarino G; Pasciuti K; Soriani A; Benassi M; Arcangeli G; Giovinazzo G; Benassi M; Marucci L
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1252-9. PubMed ID: 19251097
[TBL] [Abstract][Full Text] [Related]
9. Early Changes in Serial CBCT-Measured Parotid Gland Biomarkers Predict Chronic Xerostomia After Head and Neck Radiation Therapy.
Rosen BS; Hawkins PG; Polan DF; Balter JM; Brock KK; Kamp JD; Lockhart CM; Eisbruch A; Mierzwa ML; Ten Haken RK; El Naqa I
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1319-1329. PubMed ID: 30003997
[TBL] [Abstract][Full Text] [Related]
10. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up.
Sim C; Soong YL; Pang E; Lim C; Walker GD; Manton DJ; Reynolds EC; Wee J
Aust Dent J; 2018 Jun; 63(2):217-223. PubMed ID: 29569726
[TBL] [Abstract][Full Text] [Related]
11. Parotid gland mean dose as a xerostomia predictor in low-dose domains.
Gabryś HS; Buettner F; Sterzing F; Hauswald H; Bangert M
Acta Oncol; 2017 Sep; 56(9):1197-1203. PubMed ID: 28502238
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
[TBL] [Abstract][Full Text] [Related]
13. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.
Eisbruch A; Kim HM; Terrell JE; Marsh LH; Dawson LA; Ship JA
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):695-704. PubMed ID: 11395238
[TBL] [Abstract][Full Text] [Related]
14. Early prediction of radiotherapy-induced parotid shrinkage and toxicity based on CT radiomics and fuzzy classification.
Pota M; Scalco E; Sanguineti G; Farneti A; Cattaneo GM; Rizzo G; Esposito M
Artif Intell Med; 2017 Sep; 81():41-53. PubMed ID: 28325604
[TBL] [Abstract][Full Text] [Related]
15. A Deep Learning Model for Predicting Xerostomia Due to Radiation Therapy for Head and Neck Squamous Cell Carcinoma in the RTOG 0522 Clinical Trial.
Men K; Geng H; Zhong H; Fan Y; Lin A; Xiao Y
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):440-447. PubMed ID: 31201897
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cancer radiotherapy.
Yang X; Tridandapani S; Beitler JJ; Yu DS; Chen Z; Kim S; Bruner DW; Curran WJ; Liu T
Acad Radiol; 2014 Oct; 21(10):1304-13. PubMed ID: 25088832
[TBL] [Abstract][Full Text] [Related]
17. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
[TBL] [Abstract][Full Text] [Related]
18. Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT.
Nardone V; Tini P; Nioche C; Mazzei MA; Carfagno T; Battaglia G; Pastina P; Grassi R; Sebaste L; Pirtoli L
Radiol Med; 2018 Jun; 123(6):415-423. PubMed ID: 29368244
[TBL] [Abstract][Full Text] [Related]
19. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
[TBL] [Abstract][Full Text] [Related]
20. Xerostomia: a day and night difference.
Dijkema T; Raaijmakers CP; Braam PM; Roesink JM; Monninkhof EM; Terhaard CH
Radiother Oncol; 2012 Aug; 104(2):219-23. PubMed ID: 22809589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
